
Ericssonhas reached a “multi-year” agreement on global patent licences with Samsung, the Swedish telecom equipment maker said on Friday, ending a dispute that hit its first-quarter revenue.
Ericsson said it had not disclosed how many years the deal, which includes patents for all cellular technologies, would last. It said it now expects second-quarter patent licensing revenue to be 2 billion crowns ($237 million) to 2.5 billion crowns.
The settlement, which ends ongoing lawsuits in several countries, was done in record time as patent disputes between technology companies can often take years to settle.
The current dispute started in December, while the last tussle between the two companies was in 2012 and took two years to resolve.
The cross-licence agreement covers sales of network infrastructure and handsets from Jan. 1, 2021, it said in a statement. The companies declined to disclose the terms citing confidentiality.
Ericsson invests about 40 billion crowns every year in research and has a portfolio of more than 57,000 patents.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas